These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 9625122)

  • 1. Effects of alendronate on gastric and duodenal mucosa.
    Lanza F; Rack MF; Simon TJ; Lombardi A; Reyes R; Suryawanshi S
    Am J Gastroenterol; 1998 May; 93(5):753-7. PubMed ID: 9625122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An endoscopic comparison of the effects of alendronate and risedronate on upper gastrointestinal mucosae.
    Lanza F; Schwartz H; Sahba B; Malaty HM; Musliner T; Reyes R; Quan H; Graham DY
    Am J Gastroenterol; 2000 Nov; 95(11):3112-7. PubMed ID: 11095326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upper GI mucosal effects of parecoxib sodium in healthy elderly subjects.
    Stoltz RR; Harris SI; Kuss ME; LeComte D; Talwalker S; Dhadda S; Hubbard RC
    Am J Gastroenterol; 2002 Jan; 97(1):65-71. PubMed ID: 11808971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 14 day endoscopy study comparing risedronate and alendronate in postmenopausal women stratified by Helicobacter pylori status.
    Thomson AB; Marshall JK; Hunt RH; Provenza JM; Lanza FL; Royer MG; Li Z; Blank MA;
    J Rheumatol; 2002 Sep; 29(9):1965-74. PubMed ID: 12233894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter, randomized, double-blind, active-comparator, placebo-controlled, parallel-group comparison of the incidence of endoscopic gastric and duodenal ulcer rates with valdecoxib or naproxen in healthy subjects aged 65 to 75 years.
    Goldstein JL; Aisenberg J; Lanza F; Schwartz H; Sands GH; Berger MF; Pan S
    Clin Ther; 2006 Mar; 28(3):340-51. PubMed ID: 16750449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The upper GI safety and tolerability of oral alendronate at a dose of 70 milligrams once weekly: a placebo-controlled endoscopy study.
    Lanza F; Sahba B; Schwartz H; Winograd S; Torosis J; Quan H; Reyes R; Musliner T; Daifotis A; Leung A
    Am J Gastroenterol; 2002 Jan; 97(1):58-64. PubMed ID: 11808969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ibuprofen lysinate and acetylsalicylic acid on gastric and duodenal mucosa. Randomized single-blind placebo-controlled endoscopic study in healthy volunteers.
    Müller P; Simon B
    Arzneimittelforschung; 1994 Jul; 44(7):840-3. PubMed ID: 7945519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind, double-dummy endoscopic comparison of the mucosal protective effects of misoprostol versus ranitidine on naproxen-induced mucosal injury to the stomach and duodenum in rheumatic patients.
    Bianchi Porro G; Lazzaroni M; Petrillo M
    Am J Gastroenterol; 1997 Apr; 92(4):663-7. PubMed ID: 9128319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Helicobacter pylori infection in gastroduodenal injury and gastric prostaglandin synthesis during long term/low dose aspirin therapy: a prospective placebo-controlled, double-blind randomized trial.
    Feldman M; Cryer B; Mallat D; Go MF
    Am J Gastroenterol; 2001 Jun; 96(6):1751-7. PubMed ID: 11419825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary amino-bisphosphonates: a new class of gastrotoxic drugs--comparison of alendronate and aspirin.
    Graham DY; Malaty HM; Goodgame R
    Am J Gastroenterol; 1997 Aug; 92(8):1322-5. PubMed ID: 9260798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind, placebo-controlled, 6-day evaluation of two doses of misoprostol in gastroduodenal mucosal protection against damage from aspirin and effect on bowel habits.
    Lanza FL; Kochman RL; Geis GS; Rack EM; Deysach LG
    Am J Gastroenterol; 1991 Dec; 86(12):1743-8. PubMed ID: 1962619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upper gastrointestinal toxicity of alendronate.
    Lowe CE; Depew WT; Vanner SJ; Paterson WG; Meddings JB
    Am J Gastroenterol; 2000 Mar; 95(3):634-40. PubMed ID: 10710050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Aspirin and gastroduodenal toxicity. A double-blind endoscopic study of the effects of placebo, aspirin and lysine acetylsalicylate in healthy subjects].
    Bretagne JF; Feuillu A; Gosselin M; Gastard J
    Gastroenterol Clin Biol; 1984 Jan; 8(1):28-32. PubMed ID: 6698337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of gastroduodenal mucosal injuries caused by low-dose aspirin therapy in patients with cerebral infarction.
    Nema H; Kato M
    J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S119-21. PubMed ID: 20586852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Helicobacter pylori eradication on anti-thrombotic dose aspirin-induced gastroduodenal mucosal injury.
    Giral A; Ozdogan O; Celikel CA; Tozun N; Ulusoy NB; Kalayci C
    J Gastroenterol Hepatol; 2004 Jul; 19(7):773-7. PubMed ID: 15209624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A blinded endoscopic comparative study of misoprostol versus sucralfate and placebo in the prevention of aspirin-induced gastric and duodenal ulceration.
    Lanza F; Peace K; Gustitus L; Rack MF; Dickson B
    Am J Gastroenterol; 1988 Feb; 83(2):143-6. PubMed ID: 3124604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An endoscopic comparison of gastroduodenal injury with over-the-counter doses of ketoprofen and acetaminophen.
    Lanza FL; Codispoti JR; Nelson EB
    Am J Gastroenterol; 1998 Jul; 93(7):1051-4. PubMed ID: 9672328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
    Goldstein JL; Huang B; Amer F; Christopoulos NG
    Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative endoscopic evaluation of the damaging effects of nonsteroidal anti-inflammatory agents on the gastric and duodenal mucosa.
    Lanza FL; Royer GL; Nelson RS; Chen TT; Seckman CE; Rack MF
    Am J Gastroenterol; 1981 Jan; 75(1):17-21. PubMed ID: 7234826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upper gastrointestinal tolerability of alendronate sodium monohydrate 10 mg once daily in postmenopausal women: a 12-week, randomized, double-blind, placebo-controlled, exploratory study.
    Adachi JD; Faraawi RY; O'Mahony MF; Nayar A; Massaad R; Evans JK; Yacik C
    Clin Ther; 2009 Aug; 31(8):1747-53. PubMed ID: 19808133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.